Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fagron Genomics is a specialized biotechnology company that develops and commercializes advanced genetic testing solutions to support personalized medicine. As a subsidiary of the global pharmaceutical compounding leader Fagron, the company bridges the gap between genomics and customized pharmacotherapy. Their portfolio includes proprietary tests such as TrichoTest for alopecia and NutriGen for personalized nutrition, which provide healthcare providers with detailed genetic insights to optimize patient treatment plans. Operating from a high-tech laboratory in Spain, Fagron Genomics utilizes next-generation sequencing and bioinformatics to analyze specific genetic variants related to drug metabolism and disease predisposition. The company's services are integrated into the broader Fagron ecosystem, enabling pharmacists and physicians to prescribe personalized compounds based on individual genetic profiles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fagron Genomics.